Immunocore Holdings IMCR
NASDAQ IMCR
$36.13 -1.44 (-3.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immunocore Holdings (IMCR) Prepaid Assets (2020 - 2026)

Immunocore Holdings (IMCR) posted Prepaid Assets of $69.6 million for Q1 2026, up 34.16% sequentially from $51.9 million in Q4 2025, and up 66.89% YoY from $41.7 million in Q1 2025.

Analysis

Immunocore Holdings (IMCR) Prepaid Assets (2020 - 2026) Analysis & Trends

Immunocore Holdings has reported Prepaid Assets for 7 years, with the latest figure at $69.6 million in Q1 2026.

  • Quarterly Prepaid Assets rose 66.89% year-over-year to $69.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.6 million (up 66.89% YoY) and the FY2025 annual result came in at $51.9 million, up 26.41% from the prior year.
  • Prepaid Assets rose to $69.6 million in Q1 2026 per IMCR's latest filing, from $51.9 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $69.6 million in Q1 2026 and troughed at $7.3 million in Q4 2022.
  • A 5-year average of $39.6 million and a median of $41.0 million in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets jumped 302.87% in 2023, then advanced 26.41% in 2025.
  • Over 5 years, Prepaid Assets stood at $7.3 million in 2022, then surged by 302.87% to $29.6 million in 2023, then surged by 38.62% to $41.0 million in 2024, then rose by 26.41% to $51.9 million in 2025, then jumped by 34.16% to $69.6 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $69.6 million, $51.9 million, and $49.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immunocore Holdings 1.85 Bn 965.54 Mn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.69 Mn
Mar 31, 2026 69.59 Mn
Dec 31, 2025 51.87 Mn
Sep 30, 2025 48.96 Mn
Jun 30, 2025 44.27 Mn
Mar 31, 2025 41.70 Mn
Dec 31, 2024 41.03 Mn
Sep 30, 2024 36.45 Mn
Jun 30, 2024 33.56 Mn
Mar 31, 2024 31.30 Mn
Dec 31, 2023 29.60 Mn
Dec 31, 2022 7.35 Mn
Dec 31, 2021 5.37 Mn
Dec 31, 2020 4.53 Mn